Kripa Ram
Executive VP & Chief Operating OfficerDr. Kripa Ram, Ph.D. is Executive VP & Chief Operating Officer of Immunocore Holdings plc from 2026. Dr. Ram serves as a Member of Supervisory Board at Kiadis Pharma N.V. since April 2021. Dr. Ram has been Vice President of Bioprocess & Manufacturing Sciences of MedImmune Inc. since December 2006. Dr. Ram leads a team of more than 80 Scientists in cell culture development and manufacture of clinical products. He has direct responsibility for cell line, cell culture medium and cell culture process development for preclinical and clinical products, as well as process scale-up, technology transfer to clinical and commercial manufacturing. He served as Senior Director of Cell Culture, fermentation and manufacturing sciences. Prior to joining MedImmune in 2004, he held a series of positions of increasing responsibility at Merck, Glaxo SmithKline and Biogen Idec. In these roles, he focused on process development, technology transfer, scale-up and licensure of biological products including vaccines, fusion proteins and MAbs. He had been a Member of Scientific Advisory Board at Repligen Corporation since March 2016. Dr. Ram holds a Bachelor's Degree in Chemical Engineering and a Doctorate in Biochemical Engineering from Rutgers University.
Positions
- Company NameImmunocore Holdings plcStock CodeIMCRPositionExecutive VP & Chief Operating OfficerColleagues
- BJBahija JallalCEO & Executive Director
- JIJohn Irving BellIndependent Non-Executive Chairman
- TATravis Alan CoyCFO, Executive VP & Head of Corporate Development
- JGJohn GollSVP, Finance & Chief Accounting Officer
- AVAnnelise VuidepotChief Science and Technology Officer & Milton Park Site Head
- KPKristine PetersonIndependent Non-Executive Director
- SKSiddharth KaulIndependent Non-Executive Director
- PJPeter John RatcliffeIndependent Non-Executive Director
